Trials / Completed
CompletedNCT00991809
Study on the Development of Opioid Induced Hyperalgesia (OIH) After Exposure to Alfentanil
A Pilot Study of Prolonged, Intermittent Exposure to Alfentanil on Opioid-Induced Hyperalgesia in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to follow a person's response to experimental pain after multiple consecutive exposures to alfentanil or diphenhydramine to see if the person can tolerate the pain more, less, or the same at the end of the study.
Detailed description
This project investigates the phenomenon of opioid-induced hyperalgesia (OIH). Opioid analgesics, in addition to their therapeutic anti-nociceptive effects, under some conditions produce pro-nociceptive effects. This phenomenon of pain or pain sensitivity being increased by prior opioid administration is called opioid-induced hyperalgesia. It is thought to be relevant both to pain management complications and to complications of opioid dependence and its treatment. This study investigated the time-course of opioid-induced hyperalgesia development in healthy normal volunteers (N=12 completers), using a series of acute alfentanil administrations (15 mg/kg mg intramuscular (IM) per day) spaced at 3-4 day intervals, with testing for pain tolerance using the cold pressor test (CPT), and mechanical quantitative sensory testing (MQST) each administered repeatedly over time within each testing day. The goal was to determine the time course of OIH development following acute opioid administration, and to assess whether this changes over repeated acute opioid administrations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfentanil | 15 mcg/kg IM |
| DRUG | Diphenhydramine | 25 mg IM |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-10-08
- Last updated
- 2017-10-06
- Results posted
- 2013-10-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00991809. Inclusion in this directory is not an endorsement.